• Secured 100-unit order for PROTEQTâ„¢ mouthguards at Winter Olympics
• FIMS commenced independent assessment of PROTEQTâ„¢ for global adoption
• Successfully launched PROTEQTâ„¢ in UK consumer market with NHS 111 integration

HITIQ Limited (ASX: HIQ) achieved major international validation milestones during the September 2025 quarter, securing Olympic deployment and commencing independent assessment by the world's leading sports medicine federation. The company secured a landmark order for 100 PROTEQTâ„¢ instrumented mouthguards to be deployed at the Winter Olympics, representing its first deployment on an Olympic stage. This program is led by Professor Yannis Pitsiladis, a member of the International Olympic Committee (IOC) Medical and Scientific Commission, Chair of the Scientific Commission of the International Federation of Sports Medicine (FIMS), and Chair of the European Federation of Sports Medicine. In parallel, FIMS is independently assessing PROTEQTâ„¢ for validation and potential adoption across high-risk and extreme sports worldwide. HITIQ also formally introduced PROTEQTâ„¢ into the UK consumer market during the quarter, integrating with NHS 111 telehealth services. The UK launch establishes a scalable model for expansion into other international markets. The company also appointed former AFL player and concussion advocate Nathan Murphy as Brand Ambassador under a multi-year agreement to drive awareness and engagement within grassroots and junior sports.

Looking ahead, the company will focus on converting ongoing validation programs into multi-year commercial contracts, expanding international deployments, and progressing North American market entry pathways. The combination of elite-level endorsements, expanding geographic reach, and a strengthened capital position positions HITIQ for continued growth as the company advances its mission to become the global standard in concussion and athlete safety technology.